JPMorgan Chase and Co Cuts NUS to Neutral from Overweight, price target: $50
- price target cut to $50 from $100
- citing the underlying business is in worse shape than anticipated. With very little visibility on the trends and some concerns about how much of "bounce back" well see in top line for 15, it is hard to justify an Overweight rating despite the weakness year to date.
--> Stock was down 19.7% yesterday after releasing numbers